RONICICLIB / Placebo in Combination With Chemotherapy in Small Cell Lung Cancer
Condition(s):Small Cell Lung CarcinomaLast Updated:June 25, 2018Terminated
Hide Studies Not Open or Pending
Condition(s):Small Cell Lung CarcinomaLast Updated:June 25, 2018Terminated
Condition(s):Small Cell Lung CarcinomaLast Updated:July 28, 2023Completed
Condition(s):Small Cell Lung Carcinoma Extensive DiseaseLast Updated:July 20, 2023Completed
Condition(s):Small Cell Lung CarcinomaLast Updated:October 18, 2010Completed
Condition(s):Small Cell Lung CarcinomaLast Updated:January 5, 2024Active, not recruiting
Condition(s):Small Cell Lung Carcinoma (SCLC)Last Updated:March 5, 2024Recruiting
Condition(s):Small Cell Lung CarcinomaLast Updated:December 28, 2018Terminated
Condition(s):Recurrent Extensive Stage Small Cell Lung CarcinomaLast Updated:September 28, 2023Recruiting
Condition(s):Extensive Stage Small Cell Lung CarcinomaLast Updated:July 23, 2019Completed
Condition(s):Recurrent Small Cell Lung CarcinomaLast Updated:June 22, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.